(Q44199178)

30 November 2017

title

Pamidronate treatment improves bone mineral density in children with Menkes disease (English)

1 reference

30 November 2017

S Kanumakala

1

1 reference

30 November 2017

A Boneh

series ordinal

2

1 reference

30 November 2017

M Zacharin

series ordinal

3

1 reference

30 November 2017

publication date

1 September 2002

1 reference

Journal of Inherited Metabolic Disease

30 November 2017

published in

1 reference

30 November 2017

volume

25

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

391-398

1 reference

Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters

30 November 2017

cites work

1 reference

12 December 2020

A repeated element in the regulatory region of the MNK gene and its deletion in a patient with occipital horn syndrome

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease

1 reference

12 December 2020

Kinky hair syndrome: serial study of radiological findings with emphasis on the similarity to the battered child syndrome

1 reference

12 December 2020

Whole body bone mineral accretion in healthy children and adolescents

1 reference

12 December 2020

Adverse effects of bisphosphonates. A comparative review

1 reference

12 December 2020

Metabolic and molecular bases of Menkes disease and occipital horn syndrome

1 reference

12 December 2020

Lethal neonatal Menkes' disease with severe vasculopathy and fractures

1 reference

12 December 2020

Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo

1 reference

12 December 2020

Molecular structure of the Menkes disease gene (ATP7A)

1 reference

12 December 2020

Bisphosphonates: mechanisms of action

1 reference

12 December 2020

Molecular mechanisms of action of bisphosphonates.

1 reference

12 December 2020

1 reference

12 December 2020

Menkes disease: underlying genetic defect and new diagnostic possibilities

1 reference

12 December 2020

Menkes disease: recent advances and new aspects

1 reference

12 December 2020

Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase

1 reference

12 December 2020

Early copper-histidine treatment for Menkes disease

1 reference

12 December 2020

Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients

1 reference

12 December 2020

Molecular genetics and pathophysiology of Menkes disease

1 reference

12 December 2020

Expression and accumulation of lysyl oxidase, elastin, and type I procollagen in human Menkes and mottled mouse fibroblasts

1 reference

12 December 2020

Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome.

1 reference

12 December 2020

A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration

1 reference

12 December 2020

Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status

1 reference

12 December 2020

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response

1 reference

12 December 2020

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

1 reference

12 December 2020

Osteoporosis pseudoglioma syndrome: treatment of spinal osteoporosis with intravenous bisphosphonates

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1020103901969

1 reference

Dimensions Publication ID

30 November 2017

1018392514

0 references

1 reference